About
Develops small molecules drug candidates in infectious & metabolic diseases and oncology
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
448
By Phase
PHASE2: 5PHASE1: 6
By Status
COMPLETED: 8RECRUITING: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06939816Lead Sponsor
Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)
PHASE2Recruiting
60 participants
Started: Jul 1, 2025 · Completed: Nov 1, 2026
NCT06425055Lead Sponsor
Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
PHASE2Active, not recruiting
20 participants
Started: Aug 1, 2024 · Completed: Oct 13, 2025
NCT04365933Lead Sponsor
A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir
PHASE2Completed
20 participants
Started: May 25, 2020 · Completed: Nov 29, 2021
NCT04465916Lead Sponsor
Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)
PHASE2Terminated
26 participants
Started: May 12, 2020 · Completed: Nov 25, 2021
NCT04037618Lead Sponsor
Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose
PHASE1Completed
6 participants
Started: Jul 24, 2019 · Completed: Aug 6, 2019
Locations (1)
Headquarters
Lyon, France
Map
Loading map...